125 related articles for article (PubMed ID: 38382379)
1. Cascade Co
Wang L; Wang T; Zhuo Y; Xu S; Liu H; Jiang X; Lu Z; Wang X; Rao H; Wu D; Wang Y; Feng B; Sun M
J Colloid Interface Sci; 2024 May; 662():962-975. PubMed ID: 38382379
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
[No Abstract] [Full Text] [Related]
3. High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X; Li D; Chen L; He H; Wang Q; Hong C; He J; Gao X; Yang Y; Jiang B; Nie G; Yan X; Gao L; Fan K
ACS Nano; 2021 Mar; 15(3):5735-5751. PubMed ID: 33705663
[TBL] [Abstract][Full Text] [Related]
4. Amorphous NiB@IrO
Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
[TBL] [Abstract][Full Text] [Related]
5. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
6. N, S-co-doped carbon/Co
Li J; Liu T; Dahlgren RA; Ye H; Wang Q; Ding Y; Gao M; Wang X; Wang H
Anal Chim Acta; 2022 Apr; 1204():339703. PubMed ID: 35397915
[TBL] [Abstract][Full Text] [Related]
7. Multi-Enzyme Activity of MIL-101 (Fe)-Derived Cascade Nano-Enzymes for Antitumor and Antimicrobial Therapy.
Sun M; Wang L; Zhuo Y; Xu S; Liu H; Jiang X; Lu Z; Wang X; Wang Y; Yue G; Feng B; Rao H; Wu D
Small; 2024 Apr; 20(17):e2309593. PubMed ID: 38126566
[TBL] [Abstract][Full Text] [Related]
8. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
9. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
10. Copper metabolism in cell death and autophagy.
Xue Q; Kang R; Klionsky DJ; Tang D; Liu J; Chen X
Autophagy; 2023 Aug; 19(8):2175-2195. PubMed ID: 37055935
[TBL] [Abstract][Full Text] [Related]
11. Engineering nanoenzymes integrating Iron-based metal organic frameworks with Pt nanoparticles for enhanced Photodynamic-Ferroptosis therapy.
Ye Y; Yu H; Chen B; Zhao Y; Lv B; Xue G; Sun Y; Cao J
J Colloid Interface Sci; 2023 Sep; 645():882-894. PubMed ID: 37178565
[TBL] [Abstract][Full Text] [Related]
12. NaYF
Chen Y; Li H; Hou B; Wu A; Wu W; Li C; Wang H; Chen D; Wang X
Small; 2024 Jan; 20(1):e2304438. PubMed ID: 37661593
[TBL] [Abstract][Full Text] [Related]
13. Superoxide Dismutase-Like Regulated Fe/Ppa@PDA/B for Synergistically Targeting Ferroptosis/Apoptosis to Enhance Anti-Tumor Efficacy.
Ding X; Wang Z; Yu Q; MichaĆ N; Roman S; Liu Y; Peng N
Adv Healthc Mater; 2023 Nov; 12(29):e2301824. PubMed ID: 37485811
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
Wan X; Song L; Pan W; Zhong H; Li N; Tang B
ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
[TBL] [Abstract][Full Text] [Related]
16. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
17. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
18. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
19. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
20. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]